Category Archives: Clinical Trials & Research

Is there a new drug to treat cannabis use disorder? – Medical News Bulletin

In this study, researchers examined whether an inhibitor drug could be used to treat those suffering from cannabis withdrawal symptoms.   Cannabis is used worldwide and the trend continues to grow. A troubling issue is that cannabis use disorder can result from the use of the drug, especially if the individual uses more potent forms….

Breast cancer drug may help treat muscle paralysis – Medical News Bulletin

Researchers in Geneva and Strasbourg recently tested tamoxifen, a breast cancer drug, as a treatment for muscle paralysis in a preclinical study. Myotubular myopathy is a genetic disorder causing muscle paralysis upon birth. With no known treatment, the vast majority of infants with this condition do not live past the age of two. Tamoxifen, a…

Is there a suitable drug for stroke recovery? – Medical News Bulletin

In this study, researchers examine the effects of a drug, fluoxetine, in improving the functional ability of those facing stroke recovery.   Stroke affects many worldwide. Disability is one of the debilitating effects after a stroke.  It is estimated that 6.5 million people worldwide are affected by post-stroke disability. Usually, post-stroke recovery involves treating depression…

Non-addictive drug in early development for chronic pain treatment – Medical News Bulletin

Researchers at Virginia Tech are testing a new drug for chronic pain treatment that may avoid the addictive effects of opioids. Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin are commonly used for mild and moderate generalized pain but may have limited effectiveness in alleviating chronic nerve pain. NSAIDs inhibit the activity of cyclooxygenase enzymes responsible…

Does lenalidomide help treat bone marrow cancer? – Medical News Bulletin

Bone marrow cancer is very difficult to treat. A recent study tested if prolonged treatment with the drug lenalidomide can help treat the disease. Multiple myeloma is a serious type of bone marrow cancer. It occurs when large numbers of a specialized type of blood cell, called plasma cells, start to grow inside the bone…

Can a peanut allergy treatment decrease life-threatening reactions? – Medical News Bulletin

Our Reader Score [Total: 0 Average: 0] Despite the rising number of peanut-allergic children in North America, no FDA approved food allergy treatment is available. A recent phase-3 trial tested a new oral peanut allergy treatment in children and adolescents. There is currently no treatment for allergy symptoms caused by peanut proteins. Peanut-allergic patients are…

A newly discovered marker could allow quick diagnosis and lung cancer treatment – Medical News Bulletin

Our Reader Score [Total: 0 Average: 0] An exciting study published in Science Translational Medicine has identified a novel protein which could aid in early diagnosis and lung cancer treatment. It has been established that many tumors rely on a constant glucose supply for supporting their growth. As the cancer cells continue to grow, many…

Trial of new drug to prevent second heart attack has promising results – Medical News Bulletin

Our Reader Score [Total: 2 Average: 5] A clinical trial of a new anti-cholesterol drug has generated promising results in reducing the chances of a second heart attack, unstable angina, or death from coronary heart disease. Acute coronary syndrome is a life-threatening health condition associated with sudden and reduced blood flow to the heart. The…

Remarkable outcomes for leukemia with chemo and immunotherapy combination – Medical News Bulletin

Our Reader Score [Total: 0 Average: 0] A recent study published in Cancer Discovery has highlighted yet another example of how a combination of chemotherapy and immunotherapy could be a way to treat acute myeloid leukemia. Acute myeloid leukemia is a type of cancer that originates in bone marrow, the site for the formation of blood cells…

Novel cancer vaccine could provide benefit against HER2-positive cancers – Medical News Bulletin

Our Reader Score [Total: 0 Average: 0] A dendritic cell-based vaccine targeting HER2 has shown immense promise in a phase-1 clinical trial, as presented at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference. HER2 is a type of receptor that is found on the surface of certain cancer cells. Specific hormones and growth factors can bind to…